BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33441289)

  • 1. [Cellular and antiviral functions of TRIM5α].
    Khalfi S; Mérindol N; Berthoux L
    Virologie (Montrouge); 2020 Dec; 24(6):369-380. PubMed ID: 33441289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-canonical role for the autophagy machinery in anti-retroviral signaling mediated by TRIM5α.
    Saha B; Chisholm D; Kell AM; Mandell MA
    PLoS Pathog; 2020 Oct; 16(10):e1009017. PubMed ID: 33052966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Capsids to Complexes: Expanding the Role of TRIM5α in the Restriction of Divergent RNA Viruses and Elements.
    Rose KM; Spada SJ; Broeckel R; McNally KL; Hirsch VM; Best SM; Bouamr F
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33801908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM5α Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation.
    Chiramel AI; Meyerson NR; McNally KL; Broeckel RM; Montoya VR; Méndez-Solís O; Robertson SJ; Sturdevant GL; Lubick KJ; Nair V; Youseff BH; Ireland RM; Bosio CM; Kim K; Luban J; Hirsch VM; Taylor RT; Bouamr F; Sawyer SL; Best SM
    Cell Rep; 2019 Jun; 27(11):3269-3283.e6. PubMed ID: 31189110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell biology of TRIM5α.
    Lukic Z; Campbell EM
    Curr HIV/AIDS Rep; 2012 Mar; 9(1):73-80. PubMed ID: 22193888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha.
    O'Connor C; Pertel T; Gray S; Robia SL; Bakowska JC; Luban J; Campbell EM
    J Virol; 2010 Jun; 84(12):5997-6006. PubMed ID: 20357094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A helical LC3-interacting region mediates the interaction between the retroviral restriction factor Trim5α and mammalian autophagy-related ATG8 proteins.
    Keown JR; Black MM; Ferron A; Yap M; Barnett MJ; Pearce FG; Stoye JP; Goldstone DC
    J Biol Chem; 2018 Nov; 293(47):18378-18386. PubMed ID: 30282803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
    Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10774-9. PubMed ID: 15249685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoproteasome activation enables human TRIM5α restriction of HIV-1.
    Jimenez-Guardeño JM; Apolonia L; Betancor G; Malim MH
    Nat Microbiol; 2019 Jun; 4(6):933-940. PubMed ID: 30886358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM5α Degradation via Autophagy Is Not Required for Retroviral Restriction.
    Imam S; Talley S; Nelson RS; Dharan A; O'Connor C; Hope TJ; Campbell EM
    J Virol; 2016 Jan; 90(7):3400-10. PubMed ID: 26764007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
    Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
    J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of viral infectivity by tripartite motif proteins.
    Towers GJ
    Hum Gene Ther; 2005 Oct; 16(10):1125-32. PubMed ID: 16218773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor.
    Stremlau M; Perron M; Lee M; Li Y; Song B; Javanbakht H; Diaz-Griffero F; Anderson DJ; Sundquist WI; Sodroski J
    Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5514-9. PubMed ID: 16540544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.
    Imam S; Kömürlü S; Mattick J; Selyutina A; Talley S; Eddins A; Diaz-Griffero F; Campbell EM
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational resilience of antiviral restriction favors primate TRIM5α in host-virus evolutionary arms races.
    Tenthorey JL; Young C; Sodeinde A; Emerman M; Malik HS
    Elife; 2020 Sep; 9():. PubMed ID: 32930662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent insights into the mechanism and consequences of TRIM5α retroviral restriction.
    Sastri J; Campbell EM
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):231-8. PubMed ID: 21247355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhesus TRIM5α disrupts the HIV-1 capsid at the inter-hexamer interfaces.
    Zhao G; Ke D; Vu T; Ahn J; Shah VB; Yang R; Aiken C; Charlton LM; Gronenborn AM; Zhang P
    PLoS Pathog; 2011 Mar; 7(3):e1002009. PubMed ID: 21455494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.
    Pawlica P; Le Sage V; Poccardi N; Tremblay MJ; Mouland AJ; Berthoux L
    J Virol; 2014 May; 88(10):5661-76. PubMed ID: 24600008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Epstein-Barr Virus Minor Capsid Protein BORF1 by TRIM5α.
    Lin LT; Lu YS; Huang HH; Chen H; Hsu SW; Chang LK
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition.
    Tareen SU; Emerman M
    Virology; 2011 Jan; 409(1):113-20. PubMed ID: 21035162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.